Clinical Trial Update: MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS [Phase 3]

View source ↗

Summary

Phase 3 trial assessing medico-economic value of fluorescence-guided surgery to optimize glioblastoma resection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Glioblastoma | Phase 3 | Status: COMPLETED